A third fatality has been recorded among patients receiving treatment with a Sarepta gene therapy, adding to the troubles ...

The direct-to-consumer (DTC) platform – called Eliquis 360 Support – will offer Eliquis (apixaban) to patients who pay for ...

The panel expressed concerns about the proposed doses of Blenrep (belantamab mafodotin) in GSK's marketing application, ...

The UK government has revealed a plan to open a biosecurity facility in Harlow, Essex, to help protect the country from ...

The 2nd Hit ID Summit is your go-to hub for drug hunters looking to crack through targets and uncover quality leads. Join 60+ ...

The company behind a search agent to assist clinical decision-making – OpenEvidence – has raised an impressive $210 million ...

Kisqali was approved for the new indication on the back of the NATALEE trial, in which adding Kisqali to standard treatment ...

EVERSANA has launched a new pharmacovigilance (PV) platform that answers the need to apply advanced data analytics and ...

With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers ...

From dissecting clinical updates to identifying novel targets beyond NLRP3, this summit brings together the brightest minds transforming the field of innate immunity and inflammation.

At ASCO 2025, Johnson & Johnson contributed more than 70 abstracts, reflecting the depth of their oncology portfolio, and ...

Draft guidance from reimbursement authority NICE has recommended use of the artificial intelligence technologies – Aidoc ...